In this study, through the combination of primate-based extreme phenotype sampling and mice model-based verification, we reveal that mutation of PRKD2 is involved in the pathogenesis of hyperinsulinemia which, in turn, results in IR and metabolic disorders. Here, PRKD2 is linked to hyperinsulinism.